https://www.gosh.nhs.uk/news/statement-regarding-recent-social-media-posts/
Statement regarding recent social media posts
5 Apr 2024, 3:51 p.m.
This statement is made in response to allegations made across social media in relation to antisemitism awareness training being planned by the Trust.
A spokesperson for Great Ormond Street Hospital said: “Great Ormond Street Hospital does not tolerate discrimination of any kind, including antisemitism. Respect for all our patients, families and colleagues, is at the heart of our ethos. We strive for GOSH to be a welcoming, inclusive and safe place for all.
“We are proud to have a multi-faith chaplaincy and four broad staff networks that are dedicated to promoting diversity, inclusion and respect within the Trust.
“It is incorrect to allege that any one community was responsible for the decision to not use Campaign Against Antisemitism to deliver training. After reviewing CAA’s content, the Trust decided they were not the right organisation for this work.
“We are in discussions with other providers to deliver this important antisemitism awareness training and will consult with our staff throughout.”
Surgeon who saved children’s sight surprised by patients, family and colleagues
Professor Chris Lloyd, consultant ophthalmic surgeon and paediatric ophthalmologist, was given a surprise to remember as a part of the BBC The One Show’s ‘One Big Thank You’.
Gentler treatment eliminates early deaths for children with relapsed leukaemia
A groundbreaking national study led by clinicians at Great Ormond Street Hospital (GOSH) has shown that children and young people with relapsed acute lymphoblastic leukaemia (ALL) can be treated safely with significantly less intensive chemotherapy.
NHS eye gene therapy restores Saffie's sight
Saffie has had her sight restored thanks to life-changing eye gene therapy for rare blindness at GOSH
£3M study led by patient voices targets pain in inflammatory arthritis
A new £3 million research programme involving Great Ormond Street Hospital and University College London researchers aims to tackle one of the largest unmet clinical needs in inflammatory arthritis – pain reduction.